{"id":"https://openalex.org/W4388047788","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0416","title":"416 Profiling ovarian cancer tumor and microenvironment with disease progression for the design of immunotherapy strategies","display_name":"416 Profiling ovarian cancer tumor and microenvironment with disease progression for the design of immunotherapy strategies","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388047788","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0416"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0416","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0416","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0416","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/465.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/465.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069198182","display_name":"Yan-Ruide Li","orcid":"https://orcid.org/0000-0002-9858-300X","observed_orcids":["https://orcid.org/0000-0002-9858-300X","https://orcid.org/0000-0002-2670-6269"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanruide Li","raw_affiliation_strings":["University of California, Los Angeles, North Hills, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, North Hills, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087549803","display_name":"Christopher Ochoa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Ochoa","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019260570","display_name":"Lili Yang","orcid":"https://orcid.org/0000-0001-6568-0404","observed_orcids":["https://orcid.org/0000-0001-6568-0404"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lili Yang","raw_affiliation_strings":["University of California, Los Angeles, North Hills, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, North Hills, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A465","last_page":"A465"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.7202000021934509,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.7202000021934509,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.09030000120401382,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.08860000222921371,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8939999938011169},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.9660000205039978},{"id":"https://openalex.org/keywords/cellular-immunotherapy","display_name":"cellular immunotherapy","score":0.8349999785423279},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.828000009059906},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.8709999918937683},{"id":"https://openalex.org/keywords/tam","display_name":"TAM","score":0.6800000071525574},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.972000002861023},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.7519999742507935},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.5649999976158142},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5690000057220459},{"id":"https://openalex.org/keywords/patient-derived-tumors","display_name":"patient-derived tumors","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6701653003692627},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6219390034675598},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5653713941574097},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5510948300361633},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5371630191802979},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5371193885803223},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.47726553678512573},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.43876171112060547},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4220358431339264},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4136110842227936},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36053961515426636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33536383509635925},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.28533482551574707}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0416","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0416","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0416","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/465.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:766c696b15c74b34a44a4b3d1e1bd173","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/766c696b15c74b34a44a4b3d1e1bd173","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0416","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0416","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0416","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/465.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6324275915","display_name":"Stem Cell-Engineered Invariant Natural Killer T Cells for Cancer Therapy","funder_award_id":"1dp2ca196335-01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6419300349","display_name":"Stem Cell-Based iNKT Cell Therapy for Cancer","funder_award_id":"TRAN1-08533","funder_id":"https://openalex.org/F4320306171","funder_display_name":"California Institute for Regenerative Medicine"},{"id":"https://openalex.org/G756990981","display_name":"Preclinical Development of An HSC-Engineered Off-The-Shelf iNKT Cell Therapy for Cancer","funder_award_id":"DISC2-11157","funder_id":"https://openalex.org/F4320306171","funder_display_name":"California Institute for Regenerative Medicine"}],"funders":[{"id":"https://openalex.org/F4320306171","display_name":"California Institute for Regenerative Medicine","ror":"https://ror.org/033m8b439"},{"id":"https://openalex.org/F4320306659","display_name":"Concern Foundation","ror":"https://ror.org/01hwjc346"},{"id":"https://openalex.org/F4320306844","display_name":"Stop Cancer","ror":"https://ror.org/05dvmdf20"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332502","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60"},{"id":"https://openalex.org/F4320337596","display_name":"Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles","ror":"https://ror.org/046rm7j60"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388047788.pdf","grobid_xml":"https://content.openalex.org/works/W4388047788.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W3211538813","https://openalex.org/W4303195213"],"related_works":["https://openalex.org/W4386859136","https://openalex.org/W3036758424","https://openalex.org/W7159809721","https://openalex.org/W2892058240","https://openalex.org/W2021532130","https://openalex.org/W4364367545","https://openalex.org/W4399423673","https://openalex.org/W7148978860","https://openalex.org/W2799391735","https://openalex.org/W2884068251"],"abstract_inverted_index":{"Background":[0],"Ovarian":[1],"cancer":[2,516],"(OC)":[3],"is":[4,452],"a":[5,9,27,37,44,92,228,254,278,342,354,363,383,399,409,420,432,453,458],"deadly":[6],"disease":[7,38,48,152],"with":[8],"high":[10],"mortality":[11],"rate":[12],"due":[13],"to":[14,81,161,270,352,381,395],"its":[15],"propensity":[16],"for":[17,85,121,127,232,296,300,306,321,333,357,366,374,391,514],"late":[18],"detection":[19],"and":[20,31,63,69,98,111,133,177,216,264,285,292,325,362,379,397,444,471,542,560],"frequent":[21],"recurrence.":[22],"Following":[23],"initial":[24],"treatment,":[25],"typically":[26],"combination":[28],"of":[29,59,66,72,95,124,130,151,209,213,223,238,281,303,313,509,534],"surgery":[30],"chemotherapy":[32],"administration,":[33],"patients":[34,110,139,147,291,553],"often":[35],"experience":[36,43],"remission":[39],"but":[40],"will":[41],"likely":[42],"relapse.":[45],"Once":[46],"the":[47,67,73,99,122,128,135,143,149,210,220,236,243,282,294,301,311,326,348,371,388,415,426,437,531,535],"has":[49],"reached":[50],"this":[51,86],"recurrent":[52,113,239,307],"state,":[53],"therapies":[54,299],"have":[55],"limited":[56],"efficacy.":[57],"Identification":[58],"novel":[60],"therapeutic":[61],"targets":[62,126],"improved":[64],"understanding":[65],"molecular":[68],"cellular":[70],"characteristics":[71],"OC":[74,104,138,146,272,290,546],"tumor":[75,96,118,167,205,214,283,475],"microenvironment":[76,476],"(TME)":[77],"are":[78],"urgently":[79],"needed":[80],"advance":[82],"treatment":[83,230,302],"options":[84],"devastating":[87],"disease.Methods":[88],"Here,":[89],"we":[90,156],"conducted":[91],"comprehensive":[93],"analysis":[94],"cells":[97,119,197,206,245,513],"TME":[100,136,252,286],"in":[101,137,202,235,249,253],"26":[102],"primary":[103,289],"patient":[105,251,547],"samples,":[106],"including":[107,169],"16":[108],"chemonaive":[109],"10":[112],"patients.":[114],"Profiling":[115],"antigens":[116,215],"on":[117],"allowed":[120],"identification":[123],"potential":[125,221,295],"development":[129],"cell-based":[131,159,175,185,298],"therapies,":[132],"profiling":[134],"yielded":[140],"insights":[141],"into":[142],"differences":[144],"between":[145],"over":[148],"course":[150],"progression.":[153],"In":[154,241],"addition,":[155,242],"developed":[157],"multiple":[158],"immunotherapies":[160],"target":[162],"OCs":[163],"identified":[164],"by":[165,341,457,477,530],"various":[166],"antigens,":[168],"chimeric":[170],"antigen":[171],"receptor":[172],"(CAR)-engineered":[173],"T":[174,183,260,479],"therapy,":[176],"allogeneic":[178,510],"HSC-engineered":[179,195,511],"invariant":[180],"natural":[181],"killer":[182],"(iNKT)":[184],"therapy.":[186],"1":[187],"2":[188],"Results":[189],"Our":[190],"results":[191],"demonstrated":[192],"that":[193],"our":[194,250,275],"iNKT(HSC-iNKT)":[196],"exhibited":[198],"robust":[199],"antitumor":[200],"efficacy":[201],"all":[203],"patient-derived":[204],"tested,":[207],"irrespective":[208],"expression":[211],"levels":[212],"CSC":[217],"markers,":[218],"supporting":[219],"utility":[222],"HSC-iNKT":[224,244],"cell":[225,284,334],"therapy":[226],"as":[227],"viable":[229],"option":[231],"OC,":[233,304],"particularly":[234,305],"setting":[237],"disease.":[240],"successfully":[246],"targeted":[247],"TAMs/MDSCs":[248],"CD1d-dependent":[255],"mechanism,":[256],"while":[257],"sparing":[258],"healthy":[259],"cells,":[261,263,266],"B":[262],"NK":[265],"indicating":[267],"their":[268],"capacity":[269],"alter":[271],"TME.Conclusions":[273],"Overall,":[274],"study":[276,527],"provides":[277],"detailed":[279],"characterization":[280],"profiles":[287],"among":[288],"suggests":[293],"developing":[297],"disease.Acknowledgements":[308],"We":[309],"thank":[310],"University":[312],"California,":[314],"Los":[315],"Angeles":[316],"(UCLA)":[317],"CFAR":[318],"Virology":[319],"Core":[320,331],"providing":[322],"human":[323],"cells;":[324],"UCLA":[327,459,532],"BSCRC":[328],"Flow":[329],"Cytometry":[330],"Facility":[332],"sorting":[335],"support.":[336],"This":[337,526],"work":[338],"was":[339,528],"supported":[340,456],"Director\u2019s":[343],"New":[344],"Innovator":[345],"Award":[346,361,369,386,406,413,424,435,448],"from":[347,370,387,414,425,436,551],"NIH":[349],"(DP2":[350],"CA196335,":[351],"L.Y.),":[353,382,419,431,443],"Partnering":[355,364],"Opportunity":[356,365],"Translational":[358],"Research":[359,403,412,421,434,440,537],"Projects":[360],"Discovery":[367,384],"Stage":[368,385],"California":[372,389],"Institute":[373,390],"Regenerative":[375,392],"Medicine":[376,393],"(CIRM":[377],"TRAN1\u201308533":[378],"DISC2\u201311157,":[380],"(DISC2\u201313505":[394],"L.Y.":[396],"S.M.),":[398,408],"Broad":[400],"Stem":[401,410],"Cell":[402,411,518],"Center":[404],"Innovative":[405],"(to":[407,418,430,442,449],"Concern":[416],"Foundation":[417,429,441],"Career":[422],"Development":[423,508],"STOP":[427],"CANCER":[428],"BSCRC-RHF":[433],"Rose":[438],"Hills":[439],"an":[445,555],"Ablon":[446],"Scholars":[447],"L.Y.).":[450],"Y.-R.L.":[451],"postdoctoral":[454],"fellow":[455],"MIMG":[460],"M.":[461],"John":[462],"Pickett":[463],"Post-Doctoral":[464],"Fellow":[465],"Award.References":[466],"Li":[467,502],"YR,":[468,487],"Wilson":[469],"M,":[470],"Yang":[472],"L.":[473],"Target":[474],"innate":[478],"cells.":[480],"Front":[481],"Immunol.":[482],"2022;":[483],"13,":[484],"999549.":[485],"10.3389/fimmu.2022.999549Li":[486],"Zhou":[488],"Y,":[489,493],"Kim":[490],"YJ.,":[491],"Zhu":[492],"Ma":[494],"F,":[495],"Yu":[496],"J,":[497],"Wang":[498],"YC,":[499],"Chen":[500],"X,":[501],"Z,":[503],"Zeng":[504],"S,":[505],"et":[506],"al.":[507],"iNKT":[512],"off-the-shelf":[515],"immunotherapy.":[517],"Rep":[519],"Med":[520],"2021;":[521],"2,":[522],"100449.":[523],"10.1016/j.xcrm.2021.100449.Ethics":[524],"Approval":[525],"approved":[529],"Office":[533],"Human":[536],"Protection":[538],"Program,":[539],"IRB":[540,543],"#10\u2013000727":[541],"#20\u2013001659.Consent":[544],"Primary":[545],"samples":[548],"were":[549],"collected":[550],"consented":[552],"through":[554],"IRB-approved":[556],"protocol":[557],"(IRB":[558],"#10\u2013000727)":[559],"processed.":[561]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-11-01T00:00:00"}